[Histonet] Changing dynamics in histotechnology

Rene J Buesa rjbuesa <@t> yahoo.com
Mon Sep 17 14:41:01 CDT 2012

The advances of science and technology cannot and should not be stopped. These are the beginnings of the XXIst century and in the same way that many (most) highly manual manufacturing jobs that left our soil to not return, in the same way histotechs have to learn new working ways, new technologies.
We cannot remain static hopping that our jobs will remain as they were yesterday or are now.
In the same way that old workers need to retrain to survive, histotechs need also to train and embrace the new technologies.
We cannot expect that if a diagnostic can be made quicker and better using a new molecular or genetic techniques the pathologists are not going to use and remain committed to the traditional ways just to "save" our positions.
It is the law of life: adapt or perish!
René J.

From: Jesus Ellin <JEllin <@t> yumaregional.org>
To: Judy O'Rourke <jorourke <@t> allied360.com> 
Cc: "histonet <@t> lists.utsouthwestern.edu" <histonet <@t> lists.utsouthwestern.edu> 
Sent: Monday, September 17, 2012 3:22 PM
Subject: Re: [Histonet] Changing dynamics in histotechnology

With mixed emotions I read this article, not because of its context or information, but rather the outlook for our future.  

I would like to pole on the histonet today, who is enter in:

1.  Digital Pathology
2.  Molecular Testing (ISH, PCR, Next Gene Sequencing)
3.  Automation Semi to complete
4.  Barcoding 

A good question to ask is, are we, as Histology professionals, positioned to make this change.  Case in point, how many people are signed up and preparing for this transition at the NSH convention this year?  

Sent from my iPad

On Sep 17, 2012, at 8:29 AM, "Judy O'Rourke" <jorourke <@t> allied360.com> wrote:

> Hello...
> In Clinical Lab Products’ just-released September issue, the article
> “Changing Dynamics in Histotechnology” addresses the challenges and trends
> you face daily. William DeSalvo, B.S., HTL(ASCP), chair, NSH Quality Control
> Committee, is quoted.
> Please share comments on CLP’s Facebook page, where I’ve just posted the
> article: 
> http://www.facebook.com/pages/Clinical-Lab-Products/56624886500#!/pages/Clin
> ical-Lab-Products/56624886500
> Thank you!
> Judy 
> JUDY O’ROURKE |  Editor
> Clinical Lab Products
> 6100 Center Drive, Suite 1020, Los Angeles, CA 90045
> office 619.659.1065 | fax 619.659.1065
> jorourke <@t> allied360.com | http://www.clpmag.com/
> Follow us on Facebook, and follow me on Twitter at @editorCLPmag
> _______________________________________________
> Histonet mailing list
> Histonet <@t> lists.utsouthwestern.edu
> http://lists.utsouthwestern.edu/mailman/listinfo/histonet

This message is confidential, intended only for the named 
recipient(s) and may contain information that is privileged 
or exempt from disclosure under applicable law.  If you are 
not the intended recipient(s), you are notified that the 
dissemination, distribution, or copying of this message is 
strictly prohibited.  If you receive this message in error, 
or are not the named recipient(s), please notify the sender 
at either the e-mail, fax, address, or telephone number 
listed above and delete this e-mail from your computer. 
Thank You.

Histonet mailing list
Histonet <@t> lists.utsouthwestern.edu

More information about the Histonet mailing list